Nuvation Bio Inc (NUVB) PT Lowered to $12 at BMO Capital on Lower Assumed Penetration Rates, but Optimistic Reiterated Ahead of Phase 1 NUV-422 Readout
Tweet Send to a Friend
BMO Capital analyst Do Kim lowered the price target on Nuvation Bio Inc (NYSE: NUVB) to $12.00 (from $16.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
